Santa Cruz Biotechnology

LY 364947-2 | Santa Cruz Biotechnology

eIF2 alpha Inhibitor, MLTK Inhibitor, p38 alpha Inhibitor, TGF beta RI Inhibitor, TGF beta RII Inhibitor, LY 364947 is a selective ATP-competitive inhibitor of TGF-β Receptor I kinase

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

  • See More